Back to Press Releases
AlloDirect·Press Release
AlloDirect Opens Its Allograft Procurement Platform to Hospitals and IDNs Nationwide
Friday, June 12, 2026
CHICAGO | June 10th, 2026 - AlloDirect, the direct sourcing platform connecting ambulatory surgery centers (ASCs) and health systems with AATB-certified tissue banks, today announced that its platform is now available to hospitals and integrated delivery networks (IDNs), in addition to surgery centers. Facilities can source grafts directly from certified tissue banks, without a sales rep or a phone call to confirm what is on the shelf.
AlloDirect began rolling V2 out privately on April 22, 2026, to facilities and tissue banks that had been waiting on the multi-tenant build. Four new accounts, including the company’s first hospital partner, came onto the platform during the early-access phase. Today’s announcement opens V2 to the broader U.S. surgery center and health system market.
“For decades our team watched surgery centers juggle multiple tissue vendors, wait days for reps to call back, and write off expired grafts they didn't know they had. This is the platform we always wanted to build. Facilities source directly from certified tissue banks, with full visibility into what's available and what it should cost."
- Rhett, Founder & CEO, AlloDirect
WHY IT MATTERS
An Industry Overdue For A Real Platform
The U.S. allograft supply chain has not had a meaningful technology upgrade in a generation. AlloDirect's industry analysis of the ASC and orthopedic biologics market finds:
- $287 million in allografts expire on facility shelves each year without ever reaching a patient.
- 63% of ASCs source from four or more tissue vendors just to fill basic case demand.
- 72% of facilities report procurement delays caused by sales-rep turnover.
- Markups of 40% or more are routinely layered onto allografts before they reach the facility, inflating the cost of care without adding clinical value.
Built around onboarding speed, not just order volume
The pilot taught the team that the real bottleneck wasn’t transaction volume-it was how long it took to onboard a new tissue bank or a new facility. V2 rebuilds the platform around that insight:
- A supplier portal for tissue banks - publish catalogs, sync inventory, and share AATB compliance documentation directly. No bespoke integration. No middle layer between the bank and the facility.
- Facility-level catalog customization - every ASC, GPO, or hospital sees only the SKUs and pricing relevant to them, configured in the platform rather than over email.
GPO- and contract-specific pricing - replacing the spreadsheet-and-PDF approach most facilities still rely on for contracted pricing.
- An expanded compliance and traceability portal - chain-of-custody, AATB documentation, and post-implant reporting unified in one workflow.
Traction since launch -> WHAT THE PLATFORM UNLOCKS
Two Ways To Source, Built Around Speed
- Live catalogs for tissue banks that choose to share availability directly, so facilities can browse and order in real time, with no bespoke integration and no middle layer.
- AI-enabled graft matching for facilities that prefer to describe what they need, surfacing the right grafts by specification, availability, and contracted pricing.
- Facility-level catalog customization, so every ASC, GPO, or hospital sees only the SKUs and pricing relevant to them.
- GPO- and contract-specific pricing, replacing the spreadsheet-and-PDF approach most facilities still rely on.
- An expanded compliance and traceability portal, unifying chain-of-custody, AATB documentation, and post-implant reporting in one workflow.
WHAT'S NEXT
Hospitals, IDNs, And Adjacent Verticals
AlloDirect is now live with surgery centers and health systems nationwide, and continues to expand the certified tissue banks and verticals available on the platform.
Facilities ready to onboard, and tissue banks interested in joining the platform, can request access at allo.direct.
About AlloDirect
AlloDirect is the direct sourcing platform connecting ambulatory surgery centers and health systems with AATB-certified tissue banks. The platform handles ordering, routing, compliance, invoicing, and analytics across the allograft and biologics procurement lifecycle, giving facilities real visibility and control over one of the highest-cost categories in their supply chain. Learn more at allo.direct.
AlloDirect began rolling V2 out privately on April 22, 2026, to facilities and tissue banks that had been waiting on the multi-tenant build. Four new accounts, including the company’s first hospital partner, came onto the platform during the early-access phase. Today’s announcement opens V2 to the broader U.S. surgery center and health system market.
“For decades our team watched surgery centers juggle multiple tissue vendors, wait days for reps to call back, and write off expired grafts they didn't know they had. This is the platform we always wanted to build. Facilities source directly from certified tissue banks, with full visibility into what's available and what it should cost."
- Rhett, Founder & CEO, AlloDirect
WHY IT MATTERS
An Industry Overdue For A Real Platform
The U.S. allograft supply chain has not had a meaningful technology upgrade in a generation. AlloDirect's industry analysis of the ASC and orthopedic biologics market finds:
- $287 million in allografts expire on facility shelves each year without ever reaching a patient.
- 63% of ASCs source from four or more tissue vendors just to fill basic case demand.
- 72% of facilities report procurement delays caused by sales-rep turnover.
- Markups of 40% or more are routinely layered onto allografts before they reach the facility, inflating the cost of care without adding clinical value.
Built around onboarding speed, not just order volume
The pilot taught the team that the real bottleneck wasn’t transaction volume-it was how long it took to onboard a new tissue bank or a new facility. V2 rebuilds the platform around that insight:
- A supplier portal for tissue banks - publish catalogs, sync inventory, and share AATB compliance documentation directly. No bespoke integration. No middle layer between the bank and the facility.
- Facility-level catalog customization - every ASC, GPO, or hospital sees only the SKUs and pricing relevant to them, configured in the platform rather than over email.
GPO- and contract-specific pricing - replacing the spreadsheet-and-PDF approach most facilities still rely on for contracted pricing.
- An expanded compliance and traceability portal - chain-of-custody, AATB documentation, and post-implant reporting unified in one workflow.
Traction since launch -> WHAT THE PLATFORM UNLOCKS
Two Ways To Source, Built Around Speed
- Live catalogs for tissue banks that choose to share availability directly, so facilities can browse and order in real time, with no bespoke integration and no middle layer.
- AI-enabled graft matching for facilities that prefer to describe what they need, surfacing the right grafts by specification, availability, and contracted pricing.
- Facility-level catalog customization, so every ASC, GPO, or hospital sees only the SKUs and pricing relevant to them.
- GPO- and contract-specific pricing, replacing the spreadsheet-and-PDF approach most facilities still rely on.
- An expanded compliance and traceability portal, unifying chain-of-custody, AATB documentation, and post-implant reporting in one workflow.
WHAT'S NEXT
Hospitals, IDNs, And Adjacent Verticals
AlloDirect is now live with surgery centers and health systems nationwide, and continues to expand the certified tissue banks and verticals available on the platform.
Facilities ready to onboard, and tissue banks interested in joining the platform, can request access at allo.direct.
About AlloDirect
AlloDirect is the direct sourcing platform connecting ambulatory surgery centers and health systems with AATB-certified tissue banks. The platform handles ordering, routing, compliance, invoicing, and analytics across the allograft and biologics procurement lifecycle, giving facilities real visibility and control over one of the highest-cost categories in their supply chain. Learn more at allo.direct.